A recent pharmacovigilance study has not only revealed a significant increase in the incidence of VEGF(R)i-associated hypertension, but also elucidated its potential biological mechanisms [10], thereby providing crucial evidence for the clinical management of VEGF(R)i-related hypertension. Here, VEGFA is linked to hypertensive disorder.